Progyny Reports Record Growth and Increased Full-Year Guidance
Progyny (PGNY) reported a highly successful selling season for the upcoming 2027 plan year, adding a record 1.3 million new covered lives through more than 85 new clients. This expansion brings the company's total reach to 8.3 million covered lives. The growth is driven by high employer demand for specialized fertility and women's health benefits as corporations look to manage rising medical costs. The company is also benefiting from market consolidation, as smaller competitors struggle with profitability and scale. Additionally, Progyny has utilized its steady operating cash flow to aggressively repurchase more than 14 million shares since November 2025. Following strong performance in the first nine months of the year, management has raised the midpoint of its full-year financial guidance.
Tickers: $PGNY
Topics: Client Acquisition Corporate Benefit Plans Fertility Benefits Share Repurchases